Net Cash Provided by (Used in) Financing Activities in USD of NKGen Biotech, Inc. from 2021 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
NKGen Biotech, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2021 to 2024.
- NKGen Biotech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $4,007,000, a 28% decline year-over-year.
- NKGen Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $20,853,000, a 5.9% decline from 2023.
- NKGen Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $22,155,000, a 1.5% decline from 2022.
- NKGen Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $22,486,000, a 87% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)